Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 3
This trial looked at a drug called elacytarabine (pronounced el-ah-site-ar-ah-been) for people with acute myeloid leukaemia (AML). It was for people with AML that had come back or did not respond to treatment.
Recruitment start: 17 August 2010
Recruitment end: 6 December 2012
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Francis Giles Dr Gail Roboz
Clavis Pharma
NIHR Clinical Research Network: Cancer
Last reviewed: 27 Nov 2014
CRUK internal database number: 7294
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
